Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | SIGMAR1 | Q99720 | 1/20 | 0.47 |
| ▸ | FPR3 | P25089 | 3/20 | 0.44 |
| ▸ | FPR2 | P25090 | 3/20 | 0.44 |
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.43 |
| ▸ | TAAR1 | Q96RJ0 | 3/20 | 0.43 |
| ▸ | NPSR1 | Q6W5P4 | 1/20 | 0.43 |
| ▸ | POLB | P06746 | 4/20 | 0.40 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.40 |
| ▸ | HTT | P42858 | 1/20 | 0.40 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.40 |
| ▸ | TSHR | P16473 | 2/20 | 0.40 |
| ▸ | NFKB1 | P19838 | 1/20 | 0.38 |
| ▸ | KCNH2 | Q12809 | 1/20 | 0.38 |
| ▸ | STAT3 | P40763 | 1/20 | 0.38 |
| ▸ | SLC22A2 | O15244 | 1/20 | 0.38 |
| ▸ | SLC22A1 | O15245 | 1/20 | 0.38 |
| ▸ | LMNA | P02545 | 1/20 | 0.38 |
| ▸ | ACHE | P22303 | 1/20 | 0.38 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.38 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.38 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL23489118 | 1.00 | SIGMAR1 (0.47) | SIGMAR1FPR3FPR2ALDH1A1TAAR1 | |
| SCHEMBL24503495 | 0.87 | SIGMAR1 (0.46) | SIGMAR1FPR3FPR2ALDH1A1TAAR1 | |
| SCHEMBL21716641 | 0.85 | ALDH1A1 (0.46) | FPR3FPR2ALDH1A1TAAR1NPSR1 | |
| SCHEMBL21716640 | 0.85 | ALDH1A1 (0.46) | FPR3FPR2ALDH1A1TAAR1NPSR1 | |
| SCHEMBL24506182 | 0.85 | ALDH1A1 (0.46) | FPR3FPR2ALDH1A1TAAR1NPSR1 | |
| SCHEMBL21884004 | 0.85 | SIGMAR1 (0.44) | SIGMAR1FPR3FPR2ALDH1A1TAAR1 | |
| SCHEMBL24062717 | 0.85 | ALDH1A1 (0.47) | SIGMAR1FPR3FPR2ALDH1A1TAAR1 | |
| SCHEMBL24334709 | 0.73 | SIGMAR1 (0.46) | SIGMAR1FPR3FPR2ALDH1A1TAAR1 | |
| SCHEMBL24503494 | 0.72 | ALDH1A1 (0.44) | FPR3FPR2ALDH1A1TAAR1NPSR1 | |
| SCHEMBL24334710 | 0.72 | NPC1 (0.46) | SIGMAR1FPR3FPR2ALDH1A1TAAR1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-4011396-A1 | RELEASABLE CONJUGATES | QuiaPEG Pharmaceuticals AB (SE) | 2022-06-15 | — | — | EP | disclosed |
| US-20220118055-A1 | RELEASABLE GLP-1 CONJUGATES | FISH & RICHARDSON PC | 2022-04-21 | — | — | US | disclosed |
| EP-3592393-B1 | RELEASABLE CONJUGATES | QUIAPEG PHARMACEUTICALS AB (SE) | 2021-12-01 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20220118055-A1 | RELEASABLE GLP-1 CONJUGATES | GLP1R, GIPR, IAPP | SIGMAR1 2651/4885FPR3 849/4885FPR2 1559/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.